What’s Hot in Boston Biotech: Here’s the Agenda for April 16

3/27/14Follow @benthefidler

There are plenty of reasons Wall Street is jittery that a biotech bubble is about to pop. But this bull market formed for a reason: innovative new science is sprouting up all over the biotech world, and some of it is on the verge of potentially delivering some real new treatment options for patients.

With that in mind, Xconomy has brought together some of the Boston biotech scene’s top innovators, executives, and venture capitalists who are at the forefront of some of the most intriguing ideas in life sciences for our latest event, “What’s Hot in Boston Biotech.” The event will take place on the afternoon of April 16 at Biogen Idec in Cambridge, MA.

We’ll host a series of panels, stories, and in-depth, interactive discussions about big biotech ideas, emerging models of collaboration between industry and academia, and new, untraditional financing sources that would’ve been unthinkable for startup biotechs just a few years ago.

Today, we’ve posted the full agenda for the event, which you can catch here. Some of the topics we’ll cover:

—Gene Surgery with CRISPR/Cas9: Feng Zhang, Professor of Biomedical Engineering, MIT; Kevin Bitterman, Principal, Polaris Partners, and interim CEO, Editas Medicine

—The up, down, and up again story of RNA interference: John Maraganore, CEO, Alnylam Pharmaceuticals

—Combing through the microbiome for drugs: David Berry, CEO, Seres Health, and partner, Flagship Ventures

—“Super enhancers” and unorthodox drug development: Nancy Simonian, CEO, Syros Pharmaceuticals

Some other names you can expect to see:

Katrine Bosley, chairman, Genocea Biosciences, and entrepreneur-in-residence, Broad Institute

Andrew Lo, Professor of Finance, MIT Sloan School of Management

Michael Bonney, CEO, Cubist Pharmaceuticals.

Douglas Williams, EVP, Research and Development, Biogen

Steven Holtzman, EVP, Corporate Development, Biogen

Jason Rhodes, President and CFO, Epizyme

Robert Urban, Head of J&J’s Boston Innovation Center

Space is limited, and you can grab tickets at a discount if you register before Friday. There are startup and student discounts to be had as well. Looking forward to seeing everyone for a fun afternoon at Biogen on the 16th.

Ben Fidler is Xconomy's Deputy Biotechnology Editor. You can e-mail him at bfidler@xconomy.com Follow @benthefidler

By posting a comment, you agree to our terms and conditions.